RNA Therapeutics: A New Era in Precision Medicine

RNA therapeutics have become a revolutionary class of medicines, offering a previously unthinkable precision in targeting genetic and molecular pathways underlying a wide range of diseases. Unlike conventional drugs, RNA-based therapies—including antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), aptamers, and messenger RNA(mRNA)—can modulate gene expression, silence disease-causing transcripts, Or, with high specificity, substitute proteins that are insufficient. The clinical success of drugs such as Nusinersen, Patisiran, and Pegaptanib, that work well in the body and the groundbreaking creation of mRNA vaccines for COVID-19 has increased interest in RNA systems around the world.Despite significant challenges in delivery, stability, and immunogenicity, advances in lipid nanoparticles, chemical modifications, and conjugate technologies has made them more useful as medicines.Future directions suggest combination technique expanded targeting of previously "undruggable" genes using personalized RNA therapy.There is promise in this new era of precision medicine for more targeted, efficient, and adaptable treatments for genetic disorders, cancer, infectious diseases, and beyond.